Skip to content
The Nexus
HEALTHMay 4 · 06:14 UTCSCIENCE DAILY

Weight loss drug Ozempic linked to lower depression and anxiety risk

GLP-1 drugs like semaglutide, known by brand names Ozempic and Wegovy, may reduce depression and anxiety risk. A study of nearly 100,000 people found significantly fewer psychiatric hospital visits and sick days. The medications are primarily used for treating diabetes and driving weight loss.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this